Gossamer Bio, Inc. (GOSS)
0.3394
+0.01
(+2.85%)
USD |
NASDAQ |
May 15, 16:00
0.3394
0.00 (0.00%)
After-Hours: 20:00
Gossamer Bio Total Assets (Quarterly) : 172.25M for Dec. 31, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Vanda Pharmaceuticals, Inc. | 433.52M |
| Gilead Sciences, Inc. | 56.28B |
| Ironwood Pharmaceuticals, Inc. | 434.57M |
| CytomX Therapeutics, Inc. | 359.36M |
| Quince Therapeutics, Inc. | 26.62M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 295.01M |
| Shareholders Equity (Quarterly) | -122.76M |
| Debt to Equity Ratio | -1.653 |
| Current Ratio | 2.643 |
| Net Debt Paydown Yield | 0.02% |